Krop IE et al. |
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA. |
2015 |
Ann. Oncol. |
pmid:25355722
|
Sibaud V et al. |
T-DM1-related telangiectasias: a potential role in secondary bleeding events. |
2015 |
Ann. Oncol. |
pmid:25403586
|
Wall ME and Wani MC |
Antineoplastic agents from plants. |
1977 |
Annu. Rev. Pharmacol. Toxicol. |
pmid:326159
|
Maslin DN |
[Ansamycins]. |
1979 |
Antibiotiki |
pmid:37801
|
Mescher C et al. |
Left Ventricular Ejection Fraction Screening and Clinical Decision-making in Metastatic HER2-positive Breast Cancer. |
2017 |
Anticancer Res. |
pmid:28668870
|
Michel LL et al. |
T-DM1 as a New Treatment Option for Patients with Metastatic HER2-positive Breast Cancer in Clinical Practice. |
2015 |
Anticancer Res. |
pmid:26254411
|
Tanida S et al. |
Inhibition of cilia regeneration of Tetrahymena by ansamitocins, new antitumor antibiotics. |
1979 |
Antimicrob. Agents Chemother. |
pmid:475367
|
Hanka LJ and Barnett MS |
Microbiological assays and bioautography of maytansine and its homologues. |
1974 |
Antimicrob. Agents Chemother. |
pmid:15825322
|
Zhao M et al. |
Effects of the Methylmalonyl-CoA Metabolic Pathway on Ansamitocin Production in Actinosynnema pretiosum. |
2017 |
Appl. Biochem. Biotechnol. |
pmid:27787765
|
Li T et al. |
Improvement of ansamitocin P-3 production by Actinosynnema mirum with fructose as the sole carbon source. |
2015 |
Appl. Biochem. Biotechnol. |
pmid:25564203
|
Fan Y et al. |
Enhancement of UDPG synthetic pathway improves ansamitocin production in Actinosynnem pretiosum. |
2016 |
Appl. Microbiol. Biotechnol. |
pmid:26585444
|
Li S et al. |
Constitutive overexpression of asm18 increases the production and diversity of maytansinoids in Actinosynnema pretiosum. |
2016 |
Appl. Microbiol. Biotechnol. |
pmid:26572523
|
Luduena RF and Roach MC |
Contrasting effects of maytansine and vinblastine on the alkylation of tubulin sulfhydryls. |
1981 |
Arch. Biochem. Biophys. |
pmid:7305339
|
Ludueña RF et al. |
The interaction of phomopsin A with bovine brain tubulin. |
1989 |
Arch. Biochem. Biophys. |
pmid:2735765
|
Ma J et al. |
New amide N-glycosides of ansamitocins identified from Actinosynnema pretiosum. |
2007 |
Arch. Pharm. Res. |
pmid:17679541
|
Jin W et al. |
LC-HRMS quantitation of intact antibody drug conjugate trastuzumab emtansine from rat plasma. |
2018 |
Bioanalysis |
pmid:29863890
|
Carrasco-Triguero M et al. |
Immunogenicity assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine. |
2013 |
Bioanalysis |
pmid:23641693
|
Dere R et al. |
PK assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine. |
2013 |
Bioanalysis |
pmid:23641694
|
Mandelbaum-Shavit F et al. |
Binding of maytansine to rat brain tubulin. |
1976 |
Biochem. Biophys. Res. Commun. |
pmid:985482
|
Li Y et al. |
Binding selectivity of rhizoxin, phomopsin A, vinblastine, and ansamitocin P-3 to fungal tubulins: differential interactions of these antimitotic agents with brain and fungal tubulins. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1530630
|